Usage: ISTURISA is indicated for the treatment of adult patients with Cushing's disease when pituitary surgery is not viable or has not achieved a cure.
recorlev
(Levoketoconazole)
Xeris Pharmaceuticals, Inc.
Usage: RECORLEV is indicated for treating endogenous hypercortisolemia in adults with Cushing's syndrome when surgery is not an option or not curative. It is not approved for fungal infections, and its safety and effectiveness for such uses are not established.